Cita APA

Muszyński, P., Groblewska, M., Kulczyńska-Przybik, A., Kułakowska, A., & Mroczko, B. (2017). YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease. Curr Neuropharmacol.

Citación estilo Chicago

Muszyński, Paweł, Magdalena Groblewska, Agnieszka Kulczyńska-Przybik, Alina Kułakowska, y Barbara Mroczko. "YKL-40 As a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease." Curr Neuropharmacol 2017.

Cita MLA

Muszyński, Paweł, et al. "YKL-40 As a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease." Curr Neuropharmacol 2017.